- Response: The Effect of 12 Weeks Aerobic, Resistance, and Combined Exercises on Omentin-1 Levels and Insulin Resistance among Type 2 Diabetic Middle-Aged Women (Diabetes Metab J 2017;41:205-12)
-
Amanat S, Fararouei , Dianatinasab M
- KMID: 2392474
- Diabetes Metab J.
- 2017 Aug;41(4):324-325.
- doi: 10.4093/dmj.2017.41.4.324
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Corrigendum: Author's Name and Affiliation Correction: The Effect of 12 Weeks Aerobic, Resistance, and Combined Exercises on Omentin-1 Levels and Insulin Resistance among Type 2 Diabetic Middle-Aged Women
-
AminiLari , Fararouei , Amanat S, Sinaei E, Dianatinasab A, AminiLari , Daneshi N, Dianatinasab M
- KMID: 2392487
- Diabetes Metab J.
- 2017 Oct;41(5):422-422.
- doi: 10.4093/dmj.2017.41.5.422
One of the authors' names and affiliations was misprinted. -
- CITED
-
- Close
- SHARE
-
- Close
- The Effect of 12 Weeks Aerobic, Resistance, and Combined Exercises on Omentin-1 Levels and Insulin Resistance among Type 2 Diabetic Middle-Aged Women
-
AminiLari , Fararouei , Amanat S, Sinaei E, Dianatinasab S, AminiLari , Daneshi N, Dianatinasab M
- KMID: 2392495
- Diabetes Metab J.
- 2017 Jun;41(3):205-212.
- doi: 10.4093/dmj.2017.41.3.205
BACKGROUND: Recent studies have shown that omentin-1 derived from adipokines can affect physiological regulations and some metabolic dis-eases such as type 2 diabetes mellitus (T2DM). METHODS: The purpose of this study... -
- CITED
-
- Close
- SHARE
-
- Close
- Meta-analysis of the prevalence of depression among breast cancer survivors in Iran: an urgent need for community supportive care programs
-
Ahmadi Gharaei H, Dianatinasab M, Kouhestani SM, Fararouei , Moameri H, Pakzad R, Ghaiasvand R
- KMID: 2469432
- Epidemiol Health.
- 2019;41:e2019030.
- doi: 10.4178/epih.e2019030
OBJECTIVES: Depression, which is the most common comorbidity in breast cancer (BC) patients, has adverse effects on patients' quality of life, disease progress, and survival. METHODS: The protocol of this study... -
- CITED
-
- Close
- SHARE
-
- Close
